AVAXIM is an inactivated vaccine indicated for active immunisation against infection caused by the hepatitis A virus.
AVAXIM Prescribing information
Hepatitis A remains one of the most common travel-related vaccine preventable diseases, although, the incidence in travellers is declining.1
Hepatitis A is caused by a virus which is usually acquired through the consumption of food or water contaminated by human faeces. Foods such as undercooked meat and fish can be a risk as well as foods that grow close to the ground such as lettuce and strawberries. It can also be acquired through person to person contact.1
The risk of acquiring hepatitis A is highest in low-income countries with poor sanitary conditions. Regions where hepatitis A is highly endemic include the Indian sub-continent (particularly Bangladesh, India, Nepal and Pakistan), Sub-Saharan and North Africa, parts of the Far East (except Japan), South and Central America and the Middle East.1
There is no specific treatment for hepatitis A. Protection is through effective personal and food and water hygiene and vaccination.1
|
|
Presentation |
Schedule |
Further doses |
Age range |
|
|
0.5 ml prefilled syringe Available in 1 and 10 syringe packs |
1 dose |
In order to provide long-term protection, a second dose (booster) of an inactivated hepatitis A vaccine should be given. The second dose is preferably given between 6 and 12 months but may be administered up to 36 months after the first dose |
16 years + |
References:
Before you prescribe this vaccine please refer to the Prescribing information and SmPC links below.
Sanofi Pasteur is committed to providing you and your patients with a comprehensive range of support materials, including disease awareness patient leaflets and in-surgery display items.
• Simply visit https://sanofi.medisa.com
• Select the user group which best describes your role in your organisation
• Narrow your search by selecting the appropriate disease area
• Select which materials you would like to receive and how many
• Log-in or register to create an account
• Confirm your order
Date of preparation: November 2018 | SAGB.MIS.18.08.1323s
